News Related to Five-Year Survival Rate

Related coverage linked through entity extraction aliases.

Pancreatic Cancer mRNA Vaccine Shows Promise as U.S. Funding Cuts Stall Research

Jun 12, 2026

Personalized mRNA vaccines showed promise in pancreatic cancer trials with 7 of 16 patients in remission after five years. Stage 2 melanoma patients saw a 50% decreased death risk with personalized mRNA vaccines. U.S. funding cuts and policy shifts have stalled domestic mRNA cancer research while companies move trials abroad.

Many Cancer Patients Miss Genomic Testing, Study Finds

Apr 08, 2026

A JAMA Network Open study reveals roughly half of metastatic cancer patients receive genomic testing, with disparities affecting low-income, Medicare/Medicaid, and minority patients. The research highlights gaps in accessing targeted therapies despite cancer survival improvements.